TMS Co., Ltd. (JP:4891) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
TMS Co., Ltd., a biopharmaceutical company focusing on transformative medicines, will attend a corporate access event during the J.P. Morgan Annual Healthcare Conference in San Francisco in January 2025. The company is advancing its pipeline which includes treatments for acute ischemic stroke and other serious conditions.
For further insights into JP:4891 stock, check out TipRanks’ Stock Analysis page.